Extensive New Data Supporting the Use of Given Imaging Products to Be Presented at Digestive Disease Week 2011

Company Will Also Unveil Next-Generation ManoScan(TM) 3D and Digitrapper(R) Products

| Source: Given Imaging Given Imaging

YOQNEAM, ISRAEL--(Marketwire - May 3, 2011) - Given Imaging Ltd. (NASDAQ: GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that more than 150 podium and poster sessions featuring the Given Imaging product lines will be presented at the upcoming Digestive Disease Week (DDW). Included in these sessions is podium presentation #671, highlighting new data from a European multicenter study to assess the feasibility of PillCam® COLON 2* in a head-to-head comparison with colonoscopy. DDW takes place from May 7 to 10, 2011 at the McCormick Place Convention Center in Chicago, IL. Given Imaging will be exhibiting at booth #2143 throughout the conference.

At this year's DDW, clinicians will present data from studies evaluating Given Imaging's products including the PillCam® Platform, Bravo® pH Monitoring System, ManoScan™ High Resolution Manometry Platform and Digitrapper® pH System. All data presented at DDW will be embargoed until the time of presentation. Podium presentation highlights include:

  • Capsule Endoscopy (CE) in Persons Presenting With Acute Upper Gastrointestinal Hemorrhage (UGIH) - A Prospective Cohort Study (#233) on Saturday, May 7th at 2:45 pm;
  • The Effect of Treatment on High-Resolution Esophageal Pressure Topography (EPT) Achalasia Subtype (#363) on Sunday, May 8th at 8:45 am;
  • Second-Generation PillCam COLON Capsule Compared With Colonoscopy (#671) on Monday, May 9th at 8:45 am;
  • A Prospective Multicenter Blinded Cohort Study Comparing Diagnostic Yield of Capsule Endoscopy (CE) Prior to Ileocolonoscopy (IC) Compared to Small Bowel Follow Through (SBFT) Prior to IC in Patients With Suspected Crohn's Disease (CD) (#852) on Monday, May 9th at 4:45 pm.

The Given Imaging booth will feature two new products in its growing reflux and manometry portfolio, the ManoScan 3D anorectal manometry system and new Digitrapper pH-Z recorder. Additionally, the Company will launch the new Given® Connectivity Solution, enabling HL7 and DICOM interface between Given Imaging software and medical information systems. Given Imaging staff will be on hand to discuss the expanded PillCam SB indications and new pediatric indications for Bravo pH monitoring, both announced earlier this year.

*PillCam® COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.

About Digestive Disease Week
Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. DDW is jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit